SCHEMBL29439641

SCHEMBL29439641

Nc1ncnc2ccc(Cl)nc12

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 20/20 0.54
MINK1 Q8N4C8 1/20 0.46
TNIK Q9UKE5 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15587364 1.00 MAP4K4 (0.54) MAP4K4MINK1TNIK
Methyl Alcohol SCHEMBL18129025 0.94 MAP4K4 (0.50) MAP4K4
SCHEMBL25372089 0.83 MAP4K4 (0.53) MAP4K4MINK1TNIK
SCHEMBL29439674 0.81 MAP4K4 (0.38) MAP4K4
SCHEMBL22715495 0.81 MAP4K4 (0.38) MAP4K4
SCHEMBL1724431 0.79 EGFR (0.45) MAP4K4
SCHEMBL1034679 0.76 EGFR (0.43) MAP4K4
SCHEMBL22715380 0.76 EGFR (0.43) MAP4K4
SCHEMBL23000191 0.76 EGFR (0.43) MAP4K4
SCHEMBL29439719 0.76 EGFR (0.43) MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119546602-A Pyrrolidone derivatives as inhibitors of nfkb-induced kinase 詹森药业有限公司 2025-02-28 CN disclosed
CN-118908957-A Small molecule inhibitors of NF- κB induced kinase 詹森药业有限公司 2024-11-08 CN disclosed
WO-2024186839-A1 BICYCLIC ARYL SULFONAMIDES, SULFONES, AND SULFONATE ESTERS AS ANTI-PARASITIC AGENTS UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) 2024-09-12 WO disclosed
CN-114222737-B Small molecule inhibitors of NF- κB induced kinase 詹森药业有限公司 2024-07-26 CN disclosed
CN-117500803-A Amino-substituted heterocycles for the treatment of cancers with EGFR mutations 纽威伦特公司 2024-02-02 CN disclosed
EP-3976597-A1 SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE Janssen Pharmaceutica NV (BE) 2022-04-06 EP disclosed